EUVIMED · CrossrefJournal
NCODA Oncology and Hematology Meeting Abstracts
ISSN 3071-6462 · Network for Collaborative Oncology Development & Advancement (NCODA)
Latest articles
Closing the oncology education gap: Design and implementation of NCODA’s Oncology Fundamentals and Business of Oncology courses
Addressing bispecific antibody education gaps on an inpatient oncology unit through in-person education and surveys
Caregiver callbacks: Optimizing the caregiver experience in the month following bispecific T-cell engager step-up therapy through a collaborative clinic nursing and navigation process
Exploring oncology pharmacy awareness: A nationwide study among pharmacy students in Türkiye
Circulating tumor DNA as a biomarker to guide treatment escalation and de-escalation in nonsmall cell lung cancer: A review of the current evidence
Expanded institutional experience with prophylactic tocilizumab for outpatient bispecific antibody administration in community oncology
Exploring key considerations for subcutaneous anticancer therapies
Cutaneous recurrence of extramedullary multiple myeloma within surgical scar tissue
Building competency in oral anticancer medication adherence: A survey-driven education and training initiative across a multi-site oncology system
Advancing global learning in oncology through international collaboration: NCODA’s Global Congress
Assessing value-based care metrics and clinical outcomes by hormone receptor status among patients with human epidermal growth factor receptor 2-positive breast cancer
Bringing clinical leadership together: An interprofessional approach to quality and operational excellence
Re-engineering systemic anticancer therapy delivery: A multi-faceted model for enhancing oncology day ward capacity and key performance indicators
Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care
Beyond staffing gaps: A scalable nursing float pool model for integrated oncology care
Developing a comprehensive community-based bispecific antibody operations program for safe step-up dosing and ongoing management
Durable efficacy and safety with lovotibeglogene autotemcel for sickle cell disease
Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center
From triage to teaching: Preparing preceptors for what’s next
Zidesamtinib efficacy and safety in patients with advanced ROS1-positive solid tumors other than non-small cell lung cancer in the ARROS-1 study
Ferric derisomaltose achieves highest likelihood of ≥1000-mg dose administered and lowest outpatient transfusion rates among intravenous iron therapies in women with iron deficiency anemia and abnormal uterine bleeding: a real-world analysis
Evaluating subcutaneous versus intravenous immunotherapies: considerations for clinical practice
Network for Collaborative Oncology Development and Advancement webinars: a virtual platform for oncology education and engagement
Pharmacist-driven outcomes for patients on oral oncology medications: clinical impact of an integrated specialty pharmacy model
Effects of food and esomeprazole on pharmacokinetics of sevabertinib
Reporting atrial fibrillation with bispecific T-cell engagers in the Food and Drug Administration Adverse Event Reporting System
Prostate-specific antigen response with darolutamide plus androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer in ARANOTE
Opportunity sizing of oral oncology medication waste at a health system specialty pharmacy
Evaluating the in vitro impact of fatty acid–binding protein 5 inhibition on bone marrow stromal cells and myeloma cells
Formulary evaluation of targeted oncology therapies: pharmaceutics and therapeutics workflow insights from a Pacific Northwest health system
EUVIMED